Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90
- David J Fulton(corresponding author),
- M. Brennan Harris,
- Bruce E. Kemp,
- Richard C Venema,
- Mario B Marrero,
- ,
- Medical College of Georgia,
- St Vincent's Institute of Medical Research,
- ,
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewSustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>Previously, using an animal model of syndrome X, the obese Zucker rat (OZR), we documented impaired endothelium-dependent vasodilation. The aim of this study was to determine whether reduced expression or altered posttranslational regulation of endothelial nitric oxide synthase (eNOS) underlies the vascular dysfunction in OZR rats. There was no significant difference in the relative abundance of eNOS in hearts, aortas, or skeletal muscle between lean Zucker rats (LZR) and OZR regardless of age. There was no difference in eNOS mRNA levels, as determined by real-time PCR, between LZR and OZR. The inability of insulin resistance to modulate eNOS expression was also documented in two additional in vivo models, the ob/ob mouse and the fructose-fed rat, and in vitro via adenoviral expression of protein tyrosine phosphatase 1B in endothelial cells. We next investigated whether changes in the acute posttranslational regulation of eNOS occurs with insulin resistance. Phosphorylation of eNOS at S632 (human S633) and T494 was not different between LZR and OZR; however, phosphorylation of S1176 was significantly enhanced in OZR. Phosphorylation of S1176 was not different in the ob/ob mouse or in fructose-fed rats. The association of heat shock protein 90 with eNOS, a key regulatory step controlling nitric oxide and aberrant O<sub>2</sub><sup>-</sup> production, was not different between OZR and LZR. Taken together, these results suggest that changes in eNOS expression or posttranslation regulation do not underlie the vascular dysfunction seen with insulin resistance and that other mechanisms, such as altered localization, reduced availability of cofactors, substrates, and the elevated production of O<sub>2</sub><sup>-</sup>, may be responsible.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages H2384-H2393Journal (Volume, Issue Number)
American Journal of Physiology - Heart and Circulatory Physiology (Volume 287, Issue 6 56-6)Publication milestones
- Published - 12/2004
Publication status
Published - 12/2004
ISSN
0363-6135Publication IDs
- Scopus: 9344236577
- PubMed: 15271670
Publication metrics
Metrics
Fractional count
4
Fractional count
0.67
Fractional count
2
Fractional count
0.33
Fractional count
4
Fractional count
1
SciVal
FWCI
1.40
SciVal
Author count
6
SciVal
citations
43
SciVal
Paper percentile
84
PlumX, opens in new tab
Citation count
47
Captures
29
Funding Details
FunderFunding number
NHLBI
R01HL074279
